FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

The FDA approved Rhodes Pharmaceuticals' supplemental application for MS CONTIN (morphine sulfate), resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain
• Noncancer Pain

Drugs mentioned

• MS CONTIN (Morphine sulfate)

Snippet

SUPPL AP for MS CONTIN (MORPHINE SULFATE)